GRP78 has been implicated in tumor progression across various cancers and is closely correlated with unfavorable prognosis of patients with glioma, lung cancer, and head and neck cancer (Figure S3A,B, Supporting Information). This evidence concerns the gene HSPA5 and central nervous system cancer.